The ‘Prefilled Syringes Market (5th edition), 2019-2030
Key Inclusions
§ An overview of the current market landscape of companiesengaged in manufacturing prefilled syringes, providing information on year ofestablishment, company size, geographical location of the headquarters andmanufacturing facilities, type of material used (glass and plastic), number ofbarrel chambers (single chamber and dual chamber), type of needle system (fixedneedle system, luer lock and luer cone) and syringe volume.
§ An overview of the current market landscape of companiesthat are developing drugs in combination with prefilled syringes, featuringinformation on year of establishment, company size, geographical location ofthe developers, target therapeutic area, phases of development, type of drugmolecule, route of administration, approval year (for marketed products), dosagedetails (for marketed products) and other approved dosage forms (for marketedproducts).
§ A detailed competitiveness analysis of the variousprefilled syringes that we came across, taking into consideration the supplierpower (based on the employee size of developer / manufacturer and theirrespective annual revenues) and key product specifications, such as number ofchambers in the barrel, number of needle systems, volume of the barrel,technological advancement / user-friendliness and other distinguishingfeatures.
§ A list of marketed drugs / therapies and pipelinecandidates that are likely to be developed in combination with prefilledsyringes in the near future, shortlisted based on an in-depth analysis thattakes into consideration various relevant parameters, such as route ofadministration, type of drug molecule, target indications, other availabledosage forms (for approved drugs) and historical annual sales information (forapproved drugs).
§ An analysis presenting potential strategic partners (primarilydrug developers) for prefilled syringe manufacturers (with regard to likelycollaboration opportunities for combination product development) based ondifferent parameters, such as pipeline strength, target therapeuticindication(s) and developer strength.
§ An analysis of the various prefilled syringe combinationproduct-related initiatives of big pharma players, based on parameters, such ascurrent adoption (based on number of approved and under development prefilledsyringe combination products) and likely future adoption (based on potentialinjectable product candidates in the pipeline that are likely to be deliveredvia prefilled syringes), target therapeutic area(s) and type of drug molecule.
§ A review of the landscape of contract fill / finish servicesproviders that offer services for prefilled syringes, featuring a list ofactive (large-sized) service providers and analysis based on a number ofrelevant parameters, such as year of establishment, company size, scale ofoperation (preclinical, clinical and commercial), type of drug molecule(biologics and small molecules), and geographical location of the serviceprovider.
§ A detailed discussion on various safety features (add-onand integrated devices) installed in recent versions of prefilled syringes andthe companies involved in developing and manufacturing such solutions.
§ An informative summary of various guidelines establishedand issued by major regulatory bodies for the approval of prefilled syringes,across different countries / geographical regions.
§ Brief discussions of currently available specialtysyringes, which include prefilled flush syringes, prefilled diluent syringesystems and prefilled contrast agent delivery systems.
§ A case study on companies that are engaged in themanufacturing of autoinjectors, featuring brief profiles of key players in thisdomain; each profile includes an overview of the firm, and information on itsrespective product portfolio.
§ Elaborate profiles of prominent prefilled syringemanufacturers engaged in this domain, featuring a brief overview of thecompany, its financial information (if available), information on productportfolio, recent developments and an informed future outlook.
The report also features thelikely distribution of the current and forecasted opportunity across importantmarket segments, mentioned below:
- Target therapeutic area
§ Autoimmune disorders
§ Infectious diseases
§ Neurologicaldisorders
§ Blood disorders
§ Oncological disorders
§ Psychiatric disorders
§ Respiratory disorders
§ Cardiovasculardisorders
§ Metabolic disorders
§ Ophthalmic diseases
§ Orthopedic disorders
§ Others
- Type of syringe
§ Specialty syringes
- Type of syringe barrel material
§ Glass
§ Plastic
- Number of barrel chambers
§ Single chamber
§ Dual chamber
- Key geographical regions
§ North America
§ Europe
§ Latin America
§ Asia Pacific
§ Middle East andAfrica
To request samplepages, please visit this link
Key QuestionsAnswered
§ Who are the keyplayers engaged in the manufacturing of prefilled syringes, across the globe?
§ What are theprevalent trends within the prefilled syringes market?
§ Whatare the current regulatory requirements for securing marketing authorizations forprefilled syringe combination products, across different countries?
§ What technologicaladvances have taken place in the prefilled syringes market?
§ Whatare the key growth drivers within the prefilled syringes market?
§ Who are the keycontract service providers in this domain?
§ How is the currentand future market opportunity likely to be distributed across key marketsegments?
You may also be interested in the followingtitles:
1. Global AutoinjectorsMarket (3rd Edition), 2020-2030
2. Novel VaccineDelivery Devices Market, 2019-2030
4. Medical Device Labels Manufacturing Market, 2019 - 2030
Contact Us
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
